Repositioning compounds from cancer drug discovery to IPF: PI3K inhibition.
Comprehensive Pneumology Center, University Hospital, Ludwig-Maximilians-University and Helmholtz Zentrum München, Munich, Germany.
Claudia A
CA
Staab-Weijnitz
Comprehensive Pneumology Center, University Hospital, Ludwig-Maximilians-University and Helmholtz Zentrum München, Munich, Germany.
Oliver
0000-0001-7170-0360
O
Eickelberg
D000970:Antineoplastic Agents; D058492:Drug Repositioning; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis; D008175:Lung Neoplasms; D019869:Phosphatidylinositol 3-Kinases
D000970:Antineoplastic Agents; D019869:Phosphatidylinositol 3-Kinases
Idiopathic pulmonary fibrosis; Lung Cancer